Literature DB >> 18238519

Experimental determination of phase velocity of perfluorocarbons: applications to targeted contrast agents.

C S Hall1, G M Lanza, J H Rose, R J Kaufmann, R W Fuhrhop, S H Handley, K R Waters, J G Miller, S A Wickline.   

Abstract

Targeted acoustic contrast agents are designed to enhance the sensitivity and specificity of ultrasonic diagnoses. We have previously developed a ligand targeted ultrasonic contrast system that is a lipid-encapsulated, liquid-perfluorocarbon emulsion. The emulsion particles are small (250 nm) and have inherently low echogenicity unless bound to a surface by a pretargeted ligand through avidin-biotin interactions. We have recently proposed a simple acoustic transmission line model that treats the emulsion particles as a thin layer over the targeted surface. In this model, the acoustic reflectivity of the sample increases for perfluorocarbons with smaller velocities of longitudinal sound or lower densities. In this study, we measure and report the velocity of longitudinal sound for 20 perfluorocarbons using a broadband phase spectroscopic approach for estimating phase velocities. Experimentally determined velocities ranged from 520+/-2 m/sec (perfluorohexane) to 705+/-5 m/s (perfluorodecalin). No measurable dispersion was observed over the useful bandwidth of 2 to 22 MHz. Increasing carbon backbone chain length and fluorine substitution with halogens of greater atomic weight increased the measured speed of sound. Our experimental data were consistent (R=0.87) with a published empirical model that predicts velocity as a function of molecular structure. These data provide a rational basis for optimizing targeted perfluorocarbon-based contrast agents and offer further insight into the physical mechanisms responsible for the observed enhancement of surface acoustic reflectivity.

Entities:  

Year:  2000        PMID: 18238519     DOI: 10.1109/58.818750

Source DB:  PubMed          Journal:  IEEE Trans Ultrason Ferroelectr Freq Control        ISSN: 0885-3010            Impact factor:   2.725


  5 in total

1.  Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons.

Authors:  Paul S Sheeran; Samantha H Luois; Lee B Mullin; Terry O Matsunaga; Paul A Dayton
Journal:  Biomaterials       Date:  2012-01-29       Impact factor: 12.479

2.  Effects of droplet size and perfluorocarbon boiling point on the frequency dependence of acoustic vaporization threshold.

Authors:  Mitra Aliabouzar; Krishna N Kumar; Kausik Sarkar
Journal:  J Acoust Soc Am       Date:  2019-02       Impact factor: 1.840

Review 3.  Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions.

Authors:  G M Lanza; P M Winter; S D Caruthers; M S Hughes; Grace Hu; A H Schmieder; S A Wickline
Journal:  Angiogenesis       Date:  2010-04-22       Impact factor: 9.596

Review 4.  Phase-change contrast agents for imaging and therapy.

Authors:  Paul S Sheeran; Paul A Dayton
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle.

Authors:  Paul S Sheeran; Jason E Streeter; Lee B Mullin; Terry O Matsunaga; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2013-02-27       Impact factor: 2.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.